ArticleGlobalization and health2021
Managing borders during public health emergencies of international concern: a proposed typology of cross-border health measures.
Article in Globalization and health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- An analysis of WHO's Temporary Recommendations on international travel and trade measures during Public Health Emergencies of International Concern.BMJ global health · 2023Guideline
- Multi-Stakeholder Primary Health Care for Migrant Populations in Thailand's Border Regions: A Qualitative Study of Barriers and Opportunities.Journal of immigrant and minority health · 2026Article
- Policy challenges in the provision of COVID-19 border screening: evidence from eight countries.BMC public health · 2026Review
- Challenges and barriers to effective COVID-19 screening at Iran's air border crossings: a qualitative study and proposed solutions.Globalization and health · 2026Article
- Risk management during times of health uncertainty in Spain: A qualitative analysis of ethical challenges.Risk analysis : an official publication of the Society for Risk Analysis · 2025Article
- Phylogeographic evaluation of the effectiveness of Canadian travel restrictions in reducing SARS-CoV-2 variant importations and burden.Virus evolution · 2025Article
- The adoption of international travel measures during the first year of the COVID-19 pandemic: a descriptive analysis.Globalization and health · 2024Article
- The economic impact of international travel measures used during the COVID-19 pandemic: a scoping review.BMJ global health · 2024Article
- Effectiveness of international border control measures during the COVID-19 pandemic: a narrative synthesis of published systematic reviews.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2023Review
- The Unintended Consequences of Information Provision: The World Health Organization and Border Restrictions during COVID-19.International studies perspectives · 2023Article
- The implications of globalization on COVID-19 vaccination in Europe.Scientific reports · 2022Article
- Improving the management and security of COVID 19 diagnostic test data with a digital platform in resource-limited settings: The case of PlaCARD in Cameroon.PLOS digital health · 2022Article
- Fifteen days in December: capture and analysis of Omicron-related travel restrictions.BMJ global health · 2022Review
- How to organise travel restrictions in the new future: lessons from the COVID-19 response in Hong Kong and Singapore.BMJ global health · 2022Article
- Cross-border strategies for access to healthcare in violent conflict - A scoping review.Journal of migration and health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe near universal adoption of cross-border health measures during the COVID-19 pandemic worldwide has prompted significant debate about their effectiveness and compliance with international law. The number of measures used, and the range of measures applied, have far exceeded previous public health emergencies of international concern. However, efforts to advance research, policy and practice to support their effective use has been hindered by a lack of clear and consistent definition.
resultsBased on a review of existing datasets for cross-border health measures, such as the Oxford Coronavirus Government Response Tracker and World Health Organization Public Health and Social Measures, along with analysis of secondary and grey literature, we propose six categories to define measures more clearly and consistently - policy goal, type of movement (travel and trade), adopted by public or private sector, level of jurisdiction applied, stage of journey, and degree of restrictiveness. These categories are then brought together into a proposed typology that can support research with generalizable findings and comparative analyses across jurisdictions. Addressing the current gaps in evidence about travel measures, including how different jurisdictions apply such measures with varying effects, in turn, enhances the potential for evidence-informed decision-making based on fuller understanding of policy trade-offs and externalities. Finally, through the adoption of standardized terminology and creation of an agreed evidentiary base recognized across jurisdictions, the typology can support efforts to strengthen coordinated global responses to outbreaks and inform future efforts to revise the WHO International Health Regulations (2005).
conclusionsThe widespread use of cross-border health measures during the COVID-19 pandemic has prompted significant reflection on available evidence, previous practice and existing legal frameworks. The typology put forth in this paper aims to provide a starting point for strengthening research, policy and practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.